Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Self-Compassion, Health, and Empowerment (SHE RCT)

tiistai 28. heinäkuuta 2026 päivittänyt: Yang Li

Self-Compassion, Health, and Empowerment: A Randomized Controlled Trial for Chinese Immigrant Women Experiencing Intimate Partner Violence

Intimate partner violence (IPV) can have serious and lasting effects on women's mental health and well-being. Chinese immigrant women in the United States often face additional barriers to obtaining IPV and mental health support, including language, cultural, and social challenges. There is a need for culturally appropriate interventions that improve access to care and address the mental health needs of this underserved population.

The purpose of this study is to evaluate the efficacy of the Self-Compassion, Health, and Empowerment (SHE) intervention, a culturally tailored mobile health (mHealth) program designed for Chinese immigrant women experiencing IPV. Participants will be randomly assigned to either the SHE intervention or an attention control program and will complete study assessments over a 12-month follow-up period.

The results of this study will help determine whether the SHE intervention improves mental health and well-being among Chinese immigrant women experiencing IPV and may provide evidence for an accessible, culturally appropriate intervention that can be implemented more broadly.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Intimate partner violence (IPV) is a major public health problem that has profound effects on women's physical and mental health. Immigrant women are at increased risk for IPV and often face substantial barriers to accessing support and health services. Chinese immigrants are the largest Asian ethnic group in the United States, yet Chinese immigrant women experiencing IPV remain an underserved population. Cultural stigma, limited English proficiency, immigration-related concerns, social isolation, and limited availability of culturally and linguistically appropriate services contribute to disparities in access to IPV and mental health care.

Mental health problems, including depression, anxiety, and post-traumatic stress disorder (PTSD), are common among women who have experienced IPV. However, few evidence-based interventions have been developed specifically for Chinese immigrant women, and existing services often do not adequately address the cultural and structural barriers that limit access to care.

The Self-Compassion, Health, and Empowerment (SHE) intervention was developed to address these unmet needs. SHE is a culturally tailored, mobile health (mHealth) intervention that combines safety planning and empowerment strategies with self-compassion and relaxation practices to improve psychological well-being. Delivering the intervention remotely through telephone and text messaging is intended to increase accessibility, reduce barriers related to transportation, geography, stigma, and privacy, and facilitate engagement among Chinese immigrant women.

This study is a two-arm randomized controlled trial designed to evaluate the efficacy of the SHE intervention compared with an attention control condition. Participants will be randomly assigned to receive either the SHE intervention or a health education attention control program delivered with the same schedule and frequency of participant contact. The study will evaluate the effects of the intervention on mental health outcomes, including symptoms of depression, anxiety, and PTSD, as well as IPV experiences and other psychosocial outcomes, from baseline through 12 months of follow-up.

The findings from this study will provide evidence regarding the efficacy of a culturally tailored mHealth intervention to improve mental health and well-being among Chinese immigrant women experiencing IPV. If effective, the SHE intervention has the potential to increase access to culturally appropriate support and reduce disparities in mental health care for this underserved population.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

364

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Ei

Kuvaus

Inclusion Criteria:

  • Age 18 or older;
  • Self-identify as a woman;
  • Self-identify as Chinese;
  • Reside in the U.S.;
  • Self-report experiences of any physical, emotional, or sexual violence from an intimate partner within the past year;
  • Self-report symptoms of depression, anxiety, or post-traumatic stress disorder (PTSD).

Exclusion Criteria:

  • Those who cannot speak or understand Mandarin or English;
  • Those with substance use, suicidality, or who have been in mental health care for severe mental illness.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: The SHE intervention group
The intervention will consist of 6 weekly sessions. Session 1 is a phone discussion about an IPV safety brochure covering IPV information, questions from the Danger Assessment, safety planning, options, and available resources. It also includes immigrant-specific content such as immigration-related abuse, legal options for immigrants, and resources for immigrant survivors. Sessions 2-6 will focus on providing mental health self-care resources, with a specific topic assigned each week (Deep Breathing, Progressive Muscle Relaxation, Mindful Self- Compassion, Mindfulness, and Loving-Kindness). Each session includes a video introduction on 1 of our 5 topics, with accompanying audio instructions for exercises. The interventionist will guide participants to review the video at the beginning of each session and encourage them to practice the exercises presented in that session daily for 1 week.
The intervention will consist of 6 weekly sessions. Session 1 is a phone discussion about an IPV safety brochure covering IPV information, questions from the Danger Assessment, safety planning, options, and available resources. It also includes immigrant-specific content such as immigration-related abuse, legal options for immigrants, and resources for immigrant survivors. Sessions 2-6 will focus on providing mental health self-care resources, with a specific topic assigned each week (Deep Breathing, Progressive Muscle Relaxation, Mindful Self- Compassion, Mindfulness, and Loving-Kindness). Each session includes a video introduction on 1 of our 5 topics, with accompanying audio instructions for exercises. The interventionist will guide participants to review the video at the beginning of each session and encourage them to practice the exercises presented in that session daily for 1 week.
Active Comparator: The attention control group
Participants in the attention control group will receive six weekly educational sessions on nutrition and health, matched in delivery mode, timing, and frequency of contacts with the intervention group.
It consists of six weekly educational sessions focused on nutrition and health. Each week, participants will view a video on a specific nutrition-related topic and complete a quiz/homework (e.g., food label identification, healthy meal planning). Reminder and check-in messages will be sent every other day via text messages to reinforce the content and respond to any participant questions.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Depression symptoms
Aikaikkuna: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
The instrument used will be the Patient Health Questionnaire-9. The total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.
Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
Anxiety symptoms
Aikaikkuna: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
The instrument used will be the Generalized Anxiety Disorder-7. The total scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.
Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
Symptoms of post-traumatic stress disorder (PTSD)
Aikaikkuna: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
The instrument used will be the PTSD Checklist for DSM-5. The total scores range from 0 to 80, with higher scores indicating more severe PTSD symptoms.
Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Intimate partner violence
Aikaikkuna: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups
The instrument used will be the Revised Conflict Tactics Scales. Item scores within each subscale were summed, with higher scores indicating more frequent experiences of the corresponding behaviors. The scale consists of five subscales: negotiation (6 items; score range = 0-150), psychological aggression (8 items; score range = 0-200), physical assault (12 items; score range = 0-300), sexual coercion (7 items; score range = 0-175), and injury (6 items; score range = 0-150).
Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Tiistai 1. syyskuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Lauantai 31. elokuuta 2030

Opintojen valmistuminen (Arvioitu)

Lauantai 31. elokuuta 2030

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 24. heinäkuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 24. heinäkuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 29. heinäkuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Torstai 30. heinäkuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 28. heinäkuuta 2026

Viimeksi vahvistettu

Keskiviikko 1. heinäkuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa